Since activators of PKC, e.g., phorbol esters, are tumor promoters [57], while PP2A is considered to be a tumor suppressor [58], such comprehensive regulation of SLC22A5 may have implications in pathological states, in particular in cancer. The gene discussed is SLC22A5; the disease is neoplasm.